Rosselkhoznadzor urged manufacturers of veterinary drugs to start finalizing the dossier according to the rules of the EAEU

The Rosselkhoznadzor called on domestic manufacturers of veterinary drugs not to postpone the finalization of registration dossiers in accordance with the unified rules of the EAEU to the last moment, but to start this work today. Anna Babushkina, Deputy Head of the Department of State Veterinary Supervision of the Rosselkhoznadzor , stated this at the round table “On the rules for regulating the circulation of veterinary medicinal products in the customs territory of the EAEU” .

“Since the document is already in place, we can start to bring the dossier in line so that after 2024 there will be no influx. For our part, we are ready to provide consulting services and support so that by March 13, 2024, the main pool of medicines will be ready, which will immediately go into the general register of the EAEU,” she noted.

The unified rules for the circulation of veterinary drugs in the EAEU will come into force in March 2024. By this time, manufacturers need to bring the registration dossiers in line with the new rules so that drugs can freely circulate on the territory of the EAEU. The EAEU includes Kazakhstan, Kyrgyzstan, Armenia, Belarus and Russia .

During the round table, manufacturers of veterinary drugs noted that the new document is difficult to understand. Representatives of Rosselkhoznadzor, together with the Eurasian Economic Commission, promised to prepare clarifications for the new rules. This is necessary so that the supervisory authorities of the five countries interpret the provisions of the document in the same way.

Market participants also asked whether it would be possible to sell medicines for animals remotely under the new rules. Deputy Director of the Department of Sanitary, Phytosanitary and Veterinary Measures of the Eurasian Economic Commission (EEC) Vladimir Subbotin noted that this is allowed. “This issue was never raised at the project discussion stage. From our point of view, everything that is not prohibited by this document is allowed. If this point needs to be somehow clarified and regulated, please do so. I, as an expert, do not see any problems in this,” he said. At the same time, Vladimir Subbotin added that a number of veterinary drugs, for example, those containing live bacteria and viruses, would not be allowed to be sold remotely.